Corcept Therapeutics Incorporated (CORT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.50B |
| Enterprise value | 2.11B |
| Trailing P/E | 23.49 |
| Forward P/E | 20.24 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 6.87 |
| Price/book (mrq) | 5.29 |
| Enterprise value/revenue | 5.30 |
| Enterprise value/EBITDA | 16.25 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.53 |
| 52-week change 3 | 19.37% |
| S&P500 52-week change 3 | -12.46% |
| 52-week high 3 | 30.14 |
| 52-week low 3 | 17.19 |
| 50-day moving average 3 | 22.62 |
| 200-day moving average 3 | 24.35 |
Share statistics
| Avg vol (3-month) 3 | 732.5k |
| Avg vol (10-day) 3 | 596.02k |
| Shares outstanding 5 | 107.65M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 88.63M |
| % held by insiders 1 | 11.13% |
| % held by institutions 1 | 82.54% |
| Shares short (12 Jan 2023) 4 | 13.76M |
| Short ratio (12 Jan 2023) 4 | 16.79 |
| Short % of float (12 Jan 2023) 4 | 19.68% |
| Short % of shares outstanding (12 Jan 2023) 4 | 12.78% |
| Shares short (prior month 14 Dec 2022) 4 | 13.34M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 29.39% |
| Operating margin (ttm) | 31.89% |
Management effectiveness
| Return on assets (ttm) | 14.17% |
| Return on equity (ttm) | 23.06% |
Income statement
| Revenue (ttm) | 397.62M |
| Revenue per share (ttm) | 3.67 |
| Quarterly revenue growth (yoy) | 5.80% |
| Gross profit (ttm) | 360.7M |
| EBITDA | 127.69M |
| Net income avi to common (ttm) | 116.81M |
| Diluted EPS (ttm) | 0.98 |
| Quarterly earnings growth (yoy) | 13.60% |
Balance sheet
| Total cash (mrq) | 396.26M |
| Total cash per share (mrq) | 3.68 |
| Total debt (mrq) | 1.71M |
| Total debt/equity (mrq) | 0.36 |
| Current ratio (mrq) | 8.52 |
| Book value per share (mrq) | 4.40 |
Cash flow statement
| Operating cash flow (ttm) | 136.36M |
| Levered free cash flow (ttm) | 116.63M |
© 2023 Yahoo. All rights reserved.
